Biocon divests 1.88% stake in Syngene for Rs.230 crore
Biocon Ltd has divested 1.88% stake in its research arm Syngene International, for approx Rs.230 crore. In a regulatory filing the company stated, “Biocon, the promoter...
Tag : Syngene
Syngene enters into R&D pact with British drug major, GSK
Syngene International, the research arm of Biocon has entered into a multi-year research and development (R&D) pact, with British drug major GSK, to provide drug discovery services...
Syngene has appointed Jonathan Hunt as CEO-designation
Syngene International which is a research arm of Biocon, has appointed Jonathan Hunt as its CEO-designate. Syngene International said in a regulatory filing that Jonathan...
Biocon files prospectus with SEBI for Syngene IPO
The company has filed prospectus with the capital market regulator SEBI for the initial public offer of its research arm Syngene on Wednesday. The company...